Non-alcoholic steatohepatitis;Nicht alkoholische steatohepatitis

Praxis

Volumn 89, Issue 22, 2000, Pages 963-966

  Linhart, H G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Elevated liver enzymes; Fatty liver; NASH; Obesity; Steatohepatitis

Indexed keywords

ADOLESCENT; ADULT; ALCOHOLIC FATTY LIVER; CHILD; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; LIVER; LIVER FUNCTION TEST; MALE; MIDDLE AGED; PATHOLOGY; REVIEW;

ADOLESCENT; ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEPATITIS; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 0034737848     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Ludwig J., Viggiano T. R., McGill D. B., Oh B. J.: Nonalcoholic Steatohepatitis: Majo Clinic experiences with a hitherto unnamed disease. Majo Clinic Proc. 55, 434-438, 1980. (Pubitemid 10057164)
2. Powell E. E., Cooksley W. G., Hanson R., Searle J., Halliday J. W., Powell L.W.: The natural history of nonalcoholic steatohepatitis: A follow up study of forty two patients for up to 21 years. Hepatology 11, 74-80, 1990. (Pubitemid 20075105)
3. Byron D., Minuk G. Y.: Profile of an urban hospital based practice.Hepatology 24, 813-815, 1996.
4. James O., Day C.: Non- Alcoholic steatohepatitis: another disease of affluence. Lancet 353, 1634-1636, 1999. (Pubitemid 29224514)
5. Sheth S. G., Gordon F. D., Chopra S.: Nonalcoholic Steatohepatitis. Ann. Intern. Med. 126, 137-145, 1997. (Pubitemid 27058588)
6. Weltman M. D., Farrell G. C., Hall P., Ingelman-Sundberg M., Liddle C.: Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27, 128-133, 1998. (Pubitemid 28041545)
7. Yang S. Q., Lin H. Z., Lane M. D., Clemens M., Diehl A. M.: Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. 94, 2557-2562, 1997. (Pubitemid 27136914)
8. Sorbi D., Boynton J., Lindor K. D.: The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am. J. Gastroenterol. 94, 1018-1021, 1999.
9. Drenick E. J., Simmons F., Murphy J. F.: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small bowel bypass. N. Engl. J. Med. 282, 829-832, 1970.
10. Laurin J., Lindor K. D., Cripin J. S., Gossard A., Gores G. J., Ludwig J.: Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 23, 1464-1467, 1996.
11. Teli M. R., James O. F. W., Burt A. D., Bennettt M. K., Day C. P.: The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22, 1714-1719, 1995.
12. Caldwell S. H., Oelsner D. H., Iezzoni J. C., Hespenheide E. E., Battle E. H., Driscoll C. J.: Cryptogenic cirrhosis: Clinical characterisation and risk factors for underlying disease. Hepatology 29, 664-669, 1999. (Pubitemid 29109578)
13. Probst A., Probst T., Judmaier G., Vogel W.: Prognosis in nonalcoholic steatohepatitis (letter). Gastroenterology 108, 1607, 1995.